Daily SPAC Update – September 25, 2024

by | Sep 25, 2024

Breeze Holdings + YD Biopharma Deal. IVCB + OpSec Group Deal Termination. TBMC, TMTC, SKGR Votes Adjourned/Postponed. OAKU Extension Vote Today. IXAQ Extension Vote Set.

 Boardroom Alpha SPAC Resources
– Full SPAC Listing
– SPAC SEC Filings
– Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

EXTENSION VOTES
OAKU – OAK WOODS ACQUISITION CORP * vote September 25, 2024 -> extend to March 28, 2025

SPAC VOTE RESULTS
RFAC – RF ACQUISITION CORP * Extend to Mar 28, 2025 * 1,170,280 redeemed * trust $11.23

OTHER SPAC NEWS
TBMC – TRAILBLAZER MERGER CORP I * Vote Adjourn
TMTC – TMT ACQUISITION CORP * Vote Adjourn
SKGR – SK GROWTH OPPORTUNITIES CORP * Vote Postponed

SPAC DEAL & EXTENSION VOTES SET
IXAQ – Ix Acquisition Corp * EXTENSION VOTE SET: Oct 09, 2024 * trust $11.54

SPAC DEALS ANNOUNCED
Sep 25 | BRZH – Breeze Holdings Acquisition Corp * + YD Biopharma Limited
Sep 20 | FTII – Futuretech Ii Acquisition Corp * + Longevity Biomedical, Inc.

SPAC DEAL TERMINATIONS (Last 10 Days)
2024-09-25: IVCB + OpSec Group
2024-09-17: BACA + Custom Health, Inc

YESTERDAY’S TOP SPAC GAINERS
9.89% ~ $ 12.11 | XFIN – ExcelFin Acquisition Corp. (Announced)
2.25% ~ $ 10.10 | FIAC – Focus Impact Acquisition Corp. (Announced)
2.06% ~ $ 11.89 | ALSA – Alpha Star Acquisition Corp (Announced)
1.86% ~ $ 10.67 | WAVS – Western Acquisition Ventures Corp. (Announced)

YESTERDAY’S TOP SPAC LOSERS
-4.89% ~ $ 10.51 | IRAA – Tribe Capital Growth Corp I (Announced)
-3.92% ~ $ 12.01 | ADRT – Ault Disruptive Technologies Corp (Pre-Deal)
-3.35% ~ $ 11.68 | CLOE – Clover Leaf Capital Corp. (Announced)
-1.89% ~ $ 12.95 | ACAC – Acri Capital Acquisition Corp (Announced)
-1.73% ~ $ 10.81 | PFTA – Portage Fintech Acquisition Corp. (Announced)

LATEST SPAC IPO PERFORMANCE
Sep 20 | $ 10.05 | CAPN – Cayson Acquisition Corp
Sep 18 | $ 10.02 | YHNA – YHN Acquisition I Ltd
Sep 12 | $ 10.02 | FVN – Future Vision II Acquisition Corp.
Sep 06 | $ 10.00 | VCIC – Vine Hill Capital Investment Corp.
Sep 06 | $ 9.99 | POLE – Andretti Acquisition Corp. II
Aug 29 | $ 10.04 | GIG – GigCapital7 Corp.
Aug 28 | $ 9.98 | BSII – Black Spade Acquisition II Co

SPAC DEAL TERMINATIONS (Last 10 Days)
2024-09-17: BACA + Custom Health, Inc

Recent Analysis

Daily SPAC Update – October 1, 2024

Trailblazer (TBMC) and Learn CW (LCW) Shareholders Approve Extension and Deal. NPAB and LATG Set Extension Votes. BCSA Deal Termination. DSAQ and SLAMF Amend Mergers.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.